Erfaneh Aalipanah , Moein Askarpour , Mohammad Hadi Eskandari , Morteza Zare , Mandana Famouri , Alireza Bedeltavana , Mohammad Ali Mohsenpour , Zahra Sohrabi
{"title":"比较含嗜粘乳杆菌益生菌酸奶与含鼠李糖乳杆菌益生菌酸奶对超重或肥胖成年人体成分、生化指标、食欲和抑郁评分的影响:一项随机、双盲、对照临床试验。","authors":"Erfaneh Aalipanah , Moein Askarpour , Mohammad Hadi Eskandari , Morteza Zare , Mandana Famouri , Alireza Bedeltavana , Mohammad Ali Mohsenpour , Zahra Sohrabi","doi":"10.1016/j.clnesp.2025.05.045","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>The objective of this study was to compare the impact of daily consumption of <em>Akkermansia muciniphila</em> postbiotic-fortified yogurt (AMY) with <em>Lactobacillus rhamnosus</em> postbiotic-fortified yogurt (LRY) on the health parameters in overweight and obese patients.</div></div><div><h3>Methodes</h3><div>In this 8-week randomized double-blinded clinical trial, 66 people with overweight and obesity were randomly allocated to three groups: 1) AMY group (n = 22), 2) LRY group (n = 22), and 3) low-fat yogurt (LFY) as placebo (n = 22). The anthropometrics measurements, fasting blood glucose, lipid profile, liver enzymes, inflammatory and antioxidants biomarkers, appetite and mood status, physical activity and dietary intakes were measured at the beginning and end of the study. The registration number was IRCT20230522058257N1.</div></div><div><h3>Results</h3><div>In the AMY group, significant reductions were observed in waist circumference (P = 0.003), waist-to-height ratio (P = 0.004), body fat percentage (P = 0.032), aspartate aminotransferase levels (P = 0.045), and appetite scores (P = 0.047) compared with the control group. However, the results indicated that <em>Lactobacillus rhamnosus</em>-fortified yogurt did not demonstrate any beneficial impact on the health parameters.</div></div><div><h3>Conclusion</h3><div>Our findings suggest that a dairy product enriched with <em>Akkermansia muciniphila</em> postbiotic may have favorable effects on weight management and liver enzyme levels in overweight and obese individuals; however, further studies are needed to confirm these results and explore underlying mechanisms.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"68 ","pages":"Pages 438-446"},"PeriodicalIF":2.6000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparing the effects of yogurt containing Akkermansia muciniphilia postbiotic with yogurt containing Lactobacillus rhamnosus postbiotic on body composition, biochemical indices, appetite, and depression scores in overweight or obese adults: A randomized, double-blind, controlled clinical trial\",\"authors\":\"Erfaneh Aalipanah , Moein Askarpour , Mohammad Hadi Eskandari , Morteza Zare , Mandana Famouri , Alireza Bedeltavana , Mohammad Ali Mohsenpour , Zahra Sohrabi\",\"doi\":\"10.1016/j.clnesp.2025.05.045\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>The objective of this study was to compare the impact of daily consumption of <em>Akkermansia muciniphila</em> postbiotic-fortified yogurt (AMY) with <em>Lactobacillus rhamnosus</em> postbiotic-fortified yogurt (LRY) on the health parameters in overweight and obese patients.</div></div><div><h3>Methodes</h3><div>In this 8-week randomized double-blinded clinical trial, 66 people with overweight and obesity were randomly allocated to three groups: 1) AMY group (n = 22), 2) LRY group (n = 22), and 3) low-fat yogurt (LFY) as placebo (n = 22). The anthropometrics measurements, fasting blood glucose, lipid profile, liver enzymes, inflammatory and antioxidants biomarkers, appetite and mood status, physical activity and dietary intakes were measured at the beginning and end of the study. The registration number was IRCT20230522058257N1.</div></div><div><h3>Results</h3><div>In the AMY group, significant reductions were observed in waist circumference (P = 0.003), waist-to-height ratio (P = 0.004), body fat percentage (P = 0.032), aspartate aminotransferase levels (P = 0.045), and appetite scores (P = 0.047) compared with the control group. However, the results indicated that <em>Lactobacillus rhamnosus</em>-fortified yogurt did not demonstrate any beneficial impact on the health parameters.</div></div><div><h3>Conclusion</h3><div>Our findings suggest that a dairy product enriched with <em>Akkermansia muciniphila</em> postbiotic may have favorable effects on weight management and liver enzyme levels in overweight and obese individuals; however, further studies are needed to confirm these results and explore underlying mechanisms.</div></div>\",\"PeriodicalId\":10352,\"journal\":{\"name\":\"Clinical nutrition ESPEN\",\"volume\":\"68 \",\"pages\":\"Pages 438-446\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-05-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical nutrition ESPEN\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2405457725003420\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"NUTRITION & DIETETICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical nutrition ESPEN","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405457725003420","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
Comparing the effects of yogurt containing Akkermansia muciniphilia postbiotic with yogurt containing Lactobacillus rhamnosus postbiotic on body composition, biochemical indices, appetite, and depression scores in overweight or obese adults: A randomized, double-blind, controlled clinical trial
Objective
The objective of this study was to compare the impact of daily consumption of Akkermansia muciniphila postbiotic-fortified yogurt (AMY) with Lactobacillus rhamnosus postbiotic-fortified yogurt (LRY) on the health parameters in overweight and obese patients.
Methodes
In this 8-week randomized double-blinded clinical trial, 66 people with overweight and obesity were randomly allocated to three groups: 1) AMY group (n = 22), 2) LRY group (n = 22), and 3) low-fat yogurt (LFY) as placebo (n = 22). The anthropometrics measurements, fasting blood glucose, lipid profile, liver enzymes, inflammatory and antioxidants biomarkers, appetite and mood status, physical activity and dietary intakes were measured at the beginning and end of the study. The registration number was IRCT20230522058257N1.
Results
In the AMY group, significant reductions were observed in waist circumference (P = 0.003), waist-to-height ratio (P = 0.004), body fat percentage (P = 0.032), aspartate aminotransferase levels (P = 0.045), and appetite scores (P = 0.047) compared with the control group. However, the results indicated that Lactobacillus rhamnosus-fortified yogurt did not demonstrate any beneficial impact on the health parameters.
Conclusion
Our findings suggest that a dairy product enriched with Akkermansia muciniphila postbiotic may have favorable effects on weight management and liver enzyme levels in overweight and obese individuals; however, further studies are needed to confirm these results and explore underlying mechanisms.
期刊介绍:
Clinical Nutrition ESPEN is an electronic-only journal and is an official publication of the European Society for Clinical Nutrition and Metabolism (ESPEN). Nutrition and nutritional care have gained wide clinical and scientific interest during the past decades. The increasing knowledge of metabolic disturbances and nutritional assessment in chronic and acute diseases has stimulated rapid advances in design, development and clinical application of nutritional support. The aims of ESPEN are to encourage the rapid diffusion of knowledge and its application in the field of clinical nutrition and metabolism. Published bimonthly, Clinical Nutrition ESPEN focuses on publishing articles on the relationship between nutrition and disease in the setting of basic science and clinical practice. Clinical Nutrition ESPEN is available to all members of ESPEN and to all subscribers of Clinical Nutrition.